« Previous Next » Urology
Volume 70, Issue 6, Supplement 1 , Pages S22-S26 , December 2007

Is There a Better Way to Biopsy the Prostate? Prospects for a Novel Transrectal Systematic Biopsy Approach

Gerald L. Andriole
- Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Reprint requests: Gerald L. Andriole, MD, Division of Urologic Surgery, Washington University School of Medicine, 4960 Children’s Place, Campus Box 8242, St. Louis, Missouri 63110.
- Dr. Andriole is a paid consultant to Aeterna Zentaris, Onconomica, Roche, Solvay, and Viking Medical Systems; is a study investigator partially funded by Antigenics, GlaxoSmithKline, CD Searle, and Zeneca; and has financial interests in Envisioneering and Viking Medical Systems.
Travis L. Bullock
- Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Dr. Bullock has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Jay S. Belani
- Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Dr. Belani has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Erica Traxel
- Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Dr. Traxel has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Yan Yan
- Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Dr. Yan has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
David G. Bostwick
- Bostwick Laboratories, Richmond, Virginia, USA
- Dr. Bostwick is a study investigator for Bioniche, Dendreon, DiagnoCure, Endocare, Genotherapeutics, GlaxoSmithKline, and Health Tronics; and is the founder and majority shareholder in Bostwick Laboratories.
Peter A. Humphrey
- Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA
- Dr. Humphrey has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.